top of page
Search Results

1100 items found for "GPCR therapeutics"

Programs (7)

  • GPCRs in Pharmacology

    This comprehensive course is designed to provide an in-depth exploration of key concepts in pharmacology, offering a nuanced understanding of drug interactions and mechanisms of action. The curriculum is divided into four modules, each focusing on essential aspects of pharmacological principles. Whether you are a healthcare professional, researcher, or student in the life sciences, this course will enhance your knowledge and critical thinking skills in the field of pharmacology.

  • Dr. GPCR Ecosystem 2.0

    GPCR Ecosystem.

View All

Posts (531)

  • GPCR Therapeutics Expands Scientific Advisory Board

    May 2022 "Seoul, South Korea, 28 April 2022 – GPCR therapeutics, Inc., a venture-backed clinical stage company with an innovative approach to drug discovery based on targeting G Protein Coupled Receptors (GPCR GPCR just had a very successful first meeting including all the Scientific Advisory Board." Read more at the source #DrGPCR #GPCR #IndustryNews

  • GPCR Therapeutics welcomes Dr. Ed Brennan as their new Vice President, Head of Clinical Development

    Dr Brennan has extensive experience across all phases of clinical development, and across multiple therapeutic #biotech #lifesciences #appointment #GPCR #Oncology" Read more at the source #DrGPCR #GPCR #IndustryNews

  • Dr. Juan José Fung - Dr. GPCR Podcast

    GPCR Podcast is back this week with a brand new episode. Our guest is none other than Dr. Juan Jose Fung, Principal Scientist, at GPCR Therapeutics. https://buff.ly/32fzGbO #gpcr #drgpcr #podcast

View All

Other Pages (561)

  • Ep 58 with Dr. Juan José Fung

    GPCR Podcast << Back to podcast list Dr. Arthur Christopoulos About Dr. Juan José Fung Dr. Juan José Fung is a Principal Scientist at GPCR Therapeutics, Inc , a drug discovery company focused on targeting GPCR heteromers in cancer, headquartered in Seoul, Korea, with an R&D facility in the SF Brian Kobilka , studying the dimerization of GPCRs. Dr. Juan José Fung on the web LinkedIn GPCR Therapeutics Dr.

  • Ep 58 with Dr. Juan José Fung

    GPCR VideoCast << Back to VideoCast list Dr. Juan José Fung About Dr. Juan José Fung Dr. Juan José Fung is a Principal Scientist at GPCR Therapeutics, Inc , a drug discovery company focused on targeting GPCR heteromers in cancer, headquartered in Seoul, Korea, with an R&D facility in the SF Brian Kobilka , studying the dimerization of GPCRs. Dr. Juan José Fung on the web LinkedIn GPCR Therapeutics Dr.

  • 23-09 Dr GPCR Newsletter

    GPCR Symposia 2023 Last Friday, September 22nd, we had our Symposium GPCRs as Therapeutic Modalities. , Inoviem Scientific Lauren Slosky , University of Minnesota Medical School Christel Menet , Confo Therapeutics Ben Myers , University of Utah Niña Caculitan , GPCR Therapeutics Watch the GPCRs as Therapeutic Modalities Ecosystem Partners We thank Domain Therapeutics , GPCR Therapeutics , Design Pharmaceuticals , Montana Take a look at the latest news classified by topic: Adhesion GPCRs GPCR Activation and Signaling GPCR

View All